Your browser doesn't support javascript.
loading
Genomics to select treatment for patients with metastatic breast cancer.
Andre, Fabrice; Filleron, Thomas; Kamal, Maud; Mosele, Fernanda; Arnedos, Monica; Dalenc, Florence; Sablin, Marie-Paule; Campone, Mario; Bonnefoi, Hervé; Lefeuvre-Plesse, Claudia; Jacot, William; Coussy, Florence; Ferrero, Jean-Marc; Emile, George; Mouret-Reynier, Marie-Ange; Thery, Jean-Christophe; Isambert, Nicolas; Mege, Alice; Barthelemy, Philippe; You, Benoit; Hajjaji, Nawale; Lacroix, Ludovic; Rouleau, Etienne; Tran-Dien, Alicia; Boyault, Sandrine; Attignon, Valery; Gestraud, Pierre; Servant, Nicolas; Le Tourneau, Christophe; Cherif, Linda Larbi; Soubeyran, Isabelle; Montemurro, Filippo; Morel, Alain; Lusque, Amelie; Jimenez, Marta; Jacquet, Alexandra; Gonçalves, Anthony; Bachelot, Thomas; Bieche, Ivan.
Afiliação
  • Andre F; Department of Medical Oncology, Gustave Roussy, Villejuif, France. fabrice.andre@gustaveroussy.fr.
  • Filleron T; INSERM U981, Gustave Roussy, Villejuif, France. fabrice.andre@gustaveroussy.fr.
  • Kamal M; PRISM Center for personalized medicine, Gustave Roussy, Villejuif, France. fabrice.andre@gustaveroussy.fr.
  • Mosele F; Medical School, Université Paris Saclay, Kremlin Bicetre, France. fabrice.andre@gustaveroussy.fr.
  • Arnedos M; Department of Biostatistics, Institut Claudius Regaud, IUCT oncopole, Toulouse, France.
  • Dalenc F; Department of Drug Development and Innovation, Institut Curie, Saint Cloud, France.
  • Sablin MP; INSERM U981, Gustave Roussy, Villejuif, France.
  • Campone M; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Bonnefoi H; Department of Medical Oncology, Institut Claudius-Regaud IUCT oncopole and University of Paul Sabatier, Toulouse, France.
  • Lefeuvre-Plesse C; Department of Drug Development and Innovation, Institut Curie, Saint Cloud, France.
  • Jacot W; Department of Medical Oncology, Institut Curie, Paris, France.
  • Coussy F; Institut de Cancérologie de l'Ouest - René Gauducheau, Saint Herblain, University of Angers, Angers, France.
  • Ferrero JM; Department of Medical Oncology, Institut Bergonié INSERM U1218 and Université of Bordeaux, Bordeaux, France.
  • Emile G; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.
  • Mouret-Reynier MA; Department of Medical Oncology, Institut du Cancer de Montpellier, Institut de Recherche en Cancérologie de Montpellier INSERM U1194 and Montpellier University, Montpellier, France.
  • Thery JC; Department of Medical Oncology, Institut Curie, Saint-Cloud, France.
  • Isambert N; Department of Medical Oncology, Centre Antoine Lacassagne, University Côte d'Azur, Nice, France.
  • Mege A; Department of Medical Oncology, Centre François Baclesse, Caen, France.
  • Barthelemy P; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France.
  • You B; Department of Medical Oncology, Centre Hennri Becquerel, University of Medicine of Rouen, Rouen, France.
  • Hajjaji N; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Lacroix L; Institut Sainte Catherine, Avignon, France.
  • Rouleau E; Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
  • Tran-Dien A; Department of Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
  • Boyault S; Department of Medical Oncology, Centre Oscar Lambret INSERM U1192 PRISM Laboratory and University of Lille, Lille, France.
  • Attignon V; Cancer Genetics Laboratory, Department of Pathology and Medical Biology, Gustave Roussy, Villejuif, France.
  • Gestraud P; Cancer Genetics Laboratory, Department of Pathology and Medical Biology, Gustave Roussy, Villejuif, France.
  • Servant N; INSERM U981, Gustave Roussy, Villejuif, France.
  • Le Tourneau C; PRISM Center for personalized medicine, Gustave Roussy, Villejuif, France.
  • Cherif LL; Bioinformatic Core Facility, UMS AMMICA, Gustave Roussy, Villejuif, France.
  • Soubeyran I; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Montemurro F; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Morel A; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France.
  • Lusque A; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France.
  • Jimenez M; Department of Drug Development and Innovation, Institut Curie, Saint Cloud, France.
  • Jacquet A; Department of Drug Development and Innovation, Institut Curie, Saint Cloud, France.
  • Gonçalves A; Unit of Molecular Pathology - Department of Biopathology, Institut Bergonié, Bordeaux, France.
  • Bachelot T; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
  • Bieche I; Department of Innate Immunity and Immunotherapy, Institut de Cancérologie de l'Ouest - Centre Paul Papin, Angers, France.
Nature ; 610(7931): 343-348, 2022 10.
Article em En | MEDLINE | ID: mdl-36071165
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Genoma Humano / Genômica / Tomada de Decisão Clínica / Metástase Neoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Genoma Humano / Genômica / Tomada de Decisão Clínica / Metástase Neoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França